Main menu

This article has been updated from a previous version to correct the name of one of the journals that published studies on the role of TDP-43 mutations in ALS.

Scientists at the University of Pennsylvania this week announced that they have developed a yeast model that can screen for drugs that treat neurodegenerative diseases including amyotrophic lateral sclerosis.

Get the full story with GenomeWeb Premium

Only $95 for the first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.